We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Investors Should Retain Marsh & McLennan Stock for Now
Read MoreHide Full Article
Key Takeaways
Marsh & McLennan is supported by acquisitions, AI tools and a global footprint driving steady growth momentum.
MRSH launched Thrive program and plans to buy AltamarCAM to boost efficiency and expand into new markets.
MRSH faces margin pressure from rising costs and carries $18.3B debt, raising financial flexibility concerns.
Marsh & McLennan Companies, Inc. (MRSH - Free Report) is a professional services company that provides advisory and insurance solutions across risk, strategy and people globally. It is well positioned for growth, driven by strategic acquisitions, product innovation and expansion into emerging markets.
The stock has fallen 6.5% year to date compared with the industry’s 12.6% decline. The Zacks Business Services sector and the S&P 500 composite have decreased 13.9% and 7.6%, respectively, in the same time frame.
Image Source: Zacks Investment Research
Zack’s Rank and Valuation of MRSH
Marsh & McLennan currently carries a Zacks Rank #3 (Hold).
From a valuation perspective, MRSH appears to be priced at a premium. With a market capitalization of about $84.6 billion, the stock trades at a forward P/E of 16.4X, above the industry average of 14.6X, suggesting a relatively rich valuation compared to peers. The company currently holds a Value Score of B.
Image Source: Zacks Investment Research
Where Do Estimates for MRSH Stand?
The consensus mark for 2026 earnings is pegged at $10.32 per share, which has remained unchanged over the past 30 days. The consensus estimate for revenues is pegged at $28.2 billion, indicating 4.4% year-over-year growth. MRSH’s earnings beat estimates in each of the trailing four quarters, the average surprise being 3.6%.
Marsh & McLennan continues to show strong financial resilience, delivering 10.3% year-over-year growth in 2025. This performance is supported by its diverse offerings, global presence and strong client retention. To build on this momentum, the company launched its three-year Thrive program in 2025, aimed at strengthening its brand, improving efficiency and accelerating growth through automation and a more streamlined operating model.
Acquisitions remain a key growth driver. Strategic deals, including McGriff Insurance Services, have helped Marsh & McLennan expand into new markets and strengthen its middle-market presence. The planned acquisition of AltamarCAM in 2026 should further diversify its business by expanding into high-margin private asset management through its Mercer unit.
Technology is becoming central to MRSH’s strategy. Through its Business and Client Services (“BCS”) unit, the company is using advanced analytics and AI tools to move beyond traditional broking into a more data-driven advisory role. This shift allows it to offer deeper insights, command premium pricing and tap into emerging opportunities like digital infrastructure and AI-related investments.
The company also benefits from strong cash flow generation and disciplined capital allocation. Free cash flow rose 25% to $5 billion in 2025. With a dividend yield of 2.1%, above the industry average, and consistent share buybacks, Marsh & McLennan continues to return value to shareholders. It still has $5.7 billion available under its authorization and plans to deploy around $5 billion in 2026, reflecting confidence in its financial strength and future growth.
Risk Factors
Marsh & McLennan is facing rising costs, driven by higher wages, talent retention efforts and acquisition-related expenses, with total expenses increasing 11.4% year over year in 2025. These pressures could limit margin expansion and weigh on earnings growth.
The company also carried a significant debt burden of $18.3 billion at the end of 2025 compared with cash and cash equivalents of $2.7 billion. This led to higher interest expenses. Although Marsh & McLennan is taking steps to reduce debt, elevated leverage remains a concern and could affect financial flexibility going forward.
Conclusion
Given this balanced outlook of steady growth opportunities alongside margin and leverage pressures, the stock appears fairly valued at current levels, warranting a more measured stance for now.
The Zacks Consensus Estimate for Dave’s 2026 earnings is pegged at $14.56 per share, calling for 10.5% year-over-year growth. DAVE’s bottom-line estimate has witnessed three upward revisions in the past 30 days against one in the opposite direction. The consensus estimate for 2026 revenues is pinned at $693.5 million, implying 25.1% year-over-year growth.
The Zacks Consensus Estimate for Remitly Global’s 2026 earnings is pegged at 51 cents per share, calling for 59.4% year-over-year growth. RELY’s bottom-line estimate has remained stable over the past 30 days. The consensus estimate for 2026 revenues is pinned at $2 billion, implying 19.4% year-over-year growth.
The Zacks Consensus Estimate for GDS Holdings’ 2026 earnings is pegged at $1.16 per share, calling for 510.5% year-over-year growth. GDS’ bottom-line estimate has witnessed three upward revisions in the past 30 days against no movement in the opposite direction. The consensus estimate for 2026 revenues is pinned at $1.9 billion, implying 18.7% year-over-year growth.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Here's Why Investors Should Retain Marsh & McLennan Stock for Now
Key Takeaways
Marsh & McLennan Companies, Inc. (MRSH - Free Report) is a professional services company that provides advisory and insurance solutions across risk, strategy and people globally. It is well positioned for growth, driven by strategic acquisitions, product innovation and expansion into emerging markets.
The stock has fallen 6.5% year to date compared with the industry’s 12.6% decline. The Zacks Business Services sector and the S&P 500 composite have decreased 13.9% and 7.6%, respectively, in the same time frame.
Image Source: Zacks Investment Research
Zack’s Rank and Valuation of MRSH
Marsh & McLennan currently carries a Zacks Rank #3 (Hold).
From a valuation perspective, MRSH appears to be priced at a premium. With a market capitalization of about $84.6 billion, the stock trades at a forward P/E of 16.4X, above the industry average of 14.6X, suggesting a relatively rich valuation compared to peers. The company currently holds a Value Score of B.
Image Source: Zacks Investment Research
Where Do Estimates for MRSH Stand?
The consensus mark for 2026 earnings is pegged at $10.32 per share, which has remained unchanged over the past 30 days. The consensus estimate for revenues is pegged at $28.2 billion, indicating 4.4% year-over-year growth. MRSH’s earnings beat estimates in each of the trailing four quarters, the average surprise being 3.6%.
Marsh Price, Consensus and EPS Surprise
Marsh price-consensus-eps-surprise-chart | Marsh Quote
Business Tailwinds for MRSH
Marsh & McLennan continues to show strong financial resilience, delivering 10.3% year-over-year growth in 2025. This performance is supported by its diverse offerings, global presence and strong client retention. To build on this momentum, the company launched its three-year Thrive program in 2025, aimed at strengthening its brand, improving efficiency and accelerating growth through automation and a more streamlined operating model.
Acquisitions remain a key growth driver. Strategic deals, including McGriff Insurance Services, have helped Marsh & McLennan expand into new markets and strengthen its middle-market presence. The planned acquisition of AltamarCAM in 2026 should further diversify its business by expanding into high-margin private asset management through its Mercer unit.
Technology is becoming central to MRSH’s strategy. Through its Business and Client Services (“BCS”) unit, the company is using advanced analytics and AI tools to move beyond traditional broking into a more data-driven advisory role. This shift allows it to offer deeper insights, command premium pricing and tap into emerging opportunities like digital infrastructure and AI-related investments.
The company also benefits from strong cash flow generation and disciplined capital allocation. Free cash flow rose 25% to $5 billion in 2025. With a dividend yield of 2.1%, above the industry average, and consistent share buybacks, Marsh & McLennan continues to return value to shareholders. It still has $5.7 billion available under its authorization and plans to deploy around $5 billion in 2026, reflecting confidence in its financial strength and future growth.
Risk Factors
Marsh & McLennan is facing rising costs, driven by higher wages, talent retention efforts and acquisition-related expenses, with total expenses increasing 11.4% year over year in 2025. These pressures could limit margin expansion and weigh on earnings growth.
The company also carried a significant debt burden of $18.3 billion at the end of 2025 compared with cash and cash equivalents of $2.7 billion. This led to higher interest expenses. Although Marsh & McLennan is taking steps to reduce debt, elevated leverage remains a concern and could affect financial flexibility going forward.
Conclusion
Given this balanced outlook of steady growth opportunities alongside margin and leverage pressures, the stock appears fairly valued at current levels, warranting a more measured stance for now.
Key Picks
Some better-ranked stocks in the broader Business Services space are Dave Inc. (DAVE - Free Report) , Remitly Global, Inc. (RELY - Free Report) and GDS Holdings Limited (GDS - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Dave’s 2026 earnings is pegged at $14.56 per share, calling for 10.5% year-over-year growth. DAVE’s bottom-line estimate has witnessed three upward revisions in the past 30 days against one in the opposite direction. The consensus estimate for 2026 revenues is pinned at $693.5 million, implying 25.1% year-over-year growth.
The Zacks Consensus Estimate for Remitly Global’s 2026 earnings is pegged at 51 cents per share, calling for 59.4% year-over-year growth. RELY’s bottom-line estimate has remained stable over the past 30 days. The consensus estimate for 2026 revenues is pinned at $2 billion, implying 19.4% year-over-year growth.
The Zacks Consensus Estimate for GDS Holdings’ 2026 earnings is pegged at $1.16 per share, calling for 510.5% year-over-year growth. GDS’ bottom-line estimate has witnessed three upward revisions in the past 30 days against no movement in the opposite direction. The consensus estimate for 2026 revenues is pinned at $1.9 billion, implying 18.7% year-over-year growth.